PMC:7441788 / 0-367
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 79-87 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 95-97 | Disease | denotes | ET | http://purl.obolibrary.org/obo/MONDO_0005029 |
T3 | 143-167 | Disease | denotes | Coronavirus Disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 169-177 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 190-237 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 190-223 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 239-247 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 330-338 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 23-34 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T2 | 39-57 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T3 | 95-97 | Chemical | denotes | ET | http://purl.obolibrary.org/obo/CHEBI_73510 |
T4 | 98-100 | Chemical | denotes | AL | http://purl.obolibrary.org/obo/CHEBI_73770 |
T5 | 350-355 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 23-34 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T2 | 39-57 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T1 | 79-87 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T2 | 143-167 | Species | denotes | Coronavirus Disease 2019 | NCBItxid:2697049 |
T3 | 169-177 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T4 | 190-237 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | NCBItxid:2697049 |
T5 | 239-249 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T6 | 330-338 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-87 | Sentence | denotes | Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19 |
T2 | 88-90 | Sentence | denotes | J. |
T3 | 91-101 | Sentence | denotes | SUN ET AL. |
T4 | 102-123 | Sentence | denotes | POSTGRADUATE MEDICINE |
T5 | 125-133 | Sentence | denotes | Abstract |
T6 | 134-142 | Sentence | denotes | ABSTRACT |
T7 | 143-275 | Sentence | denotes | Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading worldwide. |
T8 | 276-339 | Sentence | denotes | Antiviral therapy is the most important treatment for COVID-19. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
4 | 39-57 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
41 | 190-237 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
42 | 239-249 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
5 | 79-87 | Disease | denotes | COVID-19 | MESH:C000657245 |
63 | 143-167 | Disease | denotes | Coronavirus Disease 2019 | MESH:C000657245 |
64 | 169-177 | Disease | denotes | COVID-19 | MESH:C000657245 |
65 | 330-338 | Disease | denotes | COVID-19 | MESH:C000657245 |
3 | 23-34 | Chemical | denotes | chloroquine | MESH:D002738 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 155-162 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | Disease |
T2 | 276-285 | http://purl.obolibrary.org/obo/IDO_0000559 | denotes | Antiviral |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 79-87 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 143-167 | Disease | denotes | Coronavirus Disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 169-177 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 190-237 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 239-249 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 330-338 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 23-34 | Chemical | denotes | chloroquine | MESH:D002738 |
4 | 39-57 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
5 | 79-87 | Disease | denotes | COVID-19 | MESH:C000657245 |
41 | 190-237 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
42 | 239-249 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
63 | 143-167 | Disease | denotes | Coronavirus Disease 2019 | MESH:C000657245 |
64 | 169-177 | Disease | denotes | COVID-19 | MESH:C000657245 |
65 | 330-338 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-87 | Sentence | denotes | Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19 |
T2 | 88-90 | Sentence | denotes | J. |
T3 | 91-101 | Sentence | denotes | SUN ET AL. |
T4 | 102-123 | Sentence | denotes | POSTGRADUATE MEDICINE |
T5 | 125-133 | Sentence | denotes | Abstract |
T6 | 134-142 | Sentence | denotes | ABSTRACT |
T7 | 143-275 | Sentence | denotes | Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading worldwide. |
T8 | 276-339 | Sentence | denotes | Antiviral therapy is the most important treatment for COVID-19. |